Literature DB >> 23246244

A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder.

Chi-Un Choe1, Evangelos Karamatskos, Benjamin Schattling, Frank Leypoldt, Gianpiero Liuzzi, Christian Gerloff, Manuel A Friese, Christoph Mulert.   

Abstract

Autoimmune encephalitis associated with IgG antibodies to the N-methyl-d-aspartic acid receptor subunit NR1 (NMDAR) presents with neurological symptoms, such as seizures, and especially psychiatric symptoms, such as hallucinations, psychosis, agitation and anxiety. To date, however, the pathological relevance of IgM NMDAR antibodies remains elusive. Here, we describe clinical, neuroradiological and neurobiological findings of a 28-year-old male presenting with IgM NMDAR antibodies coincident with autoimmune encephalitis characterized by symptoms of bipolar disorder. After repeated steroid treatment, cognitive and psychiatric abnormalities improved and no NMDAR antibody was detectable. Using primary neuronal cultures, we demonstrate that patient's serum containing IgM NMDAR antibodies reduced the detection of NMDAR on neuronal cells and decreased cell survival. Although NMDAR encephalitis with IgG antibodies is increasingly recognized and diagnosed, atypical presentations with NMDAR antibodies with immunoglobulin subclasses other than IgG pose a diagnostic and therapeutic challenge. Further clinical and neurobiological studies are needed to study the pathophysiological relevance of IgM NMDAR antibodies.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246244     DOI: 10.1016/j.psychres.2012.09.035

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

Review 1.  Neuronal surface antibody-mediated autoimmune encephalitis.

Authors:  Jenny J Linnoila; Myrna R Rosenfeld; Josep Dalmau
Journal:  Semin Neurol       Date:  2014-11-04       Impact factor: 3.420

2.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 3.  Glutamatergic autoencephalitides: an emerging field.

Authors:  Jessica A Panzer; Amy J Gleichman; David R Lynch
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

4.  Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein.

Authors:  Daria A Kamaeva; Liudmila P Smirnova; Svetlana N Vasilieva; Daria V Kazantseva; Alisa R Vasilieva; Svetlana A Ivanova
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

5.  Alterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes.

Authors:  Dominique Endres; Rick Dersch; Tilman Hottenrott; Evgeniy Perlov; Simon Maier; Dietrich van Calker; Benedikt Hochstuhl; Nils Venhoff; Oliver Stich; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2016-12-08       Impact factor: 4.157

6.  Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Authors:  Adam Al-Diwani; Thomas A Pollak; Alexander E Langford; Belinda R Lennox
Journal:  Front Psychiatry       Date:  2017-02-06       Impact factor: 4.157

Review 7.  Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Authors:  Franziska A Radtke; Gareth Chapman; Jeremy Hall; Yasir A Syed
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

Review 8.  Autoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice.

Authors:  Hannelore Ehrenreich
Journal:  Front Immunol       Date:  2017-03-01       Impact factor: 7.561

Review 9.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

Review 10.  Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.

Authors:  T A Pollak; K Beck; S R Irani; O D Howes; A S David; P K McGuire
Journal:  Psychopharmacology (Berl)       Date:  2015-12-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.